Horan Securities, Inc. - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 321 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
Horan Securities, Inc. ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$9,595
-5.6%
2660.0%0.00%
-20.0%
Q1 2023$10,159
-32.9%
2660.0%0.01%
-44.4%
Q4 2022$15,135
+37.6%
2660.0%0.01%
+28.6%
Q3 2022$11,000
-15.4%
2660.0%0.01%
-12.5%
Q2 2022$13,000
+18.2%
2660.0%0.01%
+33.3%
Q1 2022$11,0000.0%2660.0%0.01%
-14.3%
Q4 2021$11,000
-8.3%
2660.0%0.01%
-22.2%
Q2 2021$12,000
+9.1%
2660.0%0.01%0.0%
Q1 2021$11,0000.0%2660.0%0.01%0.0%
Q4 2020$11,000
+57.1%
2660.0%0.01%
+28.6%
Q3 2020$7,0000.0%2660.0%0.01%
-12.5%
Q2 2020$7,000
+40.0%
2660.0%0.01%
+14.3%
Q1 2020$5,000
+25.0%
2660.0%0.01%
+75.0%
Q3 2019$4,000
-20.0%
2660.0%0.00%
-33.3%
Q2 2019$5,000
+25.0%
2660.0%0.01%
+50.0%
Q1 2019$4,0000.0%2660.0%0.00%
-20.0%
Q4 2018$4,0000.0%2660.0%0.01%
+25.0%
Q3 2018$4,000
-20.0%
2660.0%0.00%
-20.0%
Q2 2018$5,0000.0%2660.0%0.01%
+25.0%
Q1 2018$5,0000.0%2660.0%0.00%
-20.0%
Q4 2017$5,0000.0%2660.0%0.01%0.0%
Q3 2017$5,000
+66.7%
2660.0%0.01%
+66.7%
Q2 2017$3,0000.0%2660.0%0.00%0.0%
Q1 2017$3,000
+50.0%
2660.0%0.00%0.0%
Q3 2016$2,0002660.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Third Security, LLC 7,048,282$126,799,00027.23%
First Light Asset Management, LLC 1,630,591$29,334,0005.01%
SNYDER CAPITAL MANAGEMENT L P 3,393,057$61,041,0003.48%
Bellevue Group AG 7,663,956$137,874,0002.67%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 307,633$5,531,0002.52%
Lombard Odier Asset Management (Switzerland) SA 900,000$16,191,0002.17%
Elk Creek Partners, LLC 654,362$11,772,0002.02%
DOHENY ASSET MANAGEMENT /CA 127,110$2,254,0001.79%
Granite Investment Partners, LLC 1,277,438$22,981,0001.49%
Amia Capital LLP 69,409$1,249,0001.11%
View complete list of HALOZYME THERAPEUTICS INC shareholders